Statin Bibliography of free accessible medical and biological reviews

Nr.	Year OPEN	Title	rate good	rate bad	no link	Citation
1	2008	Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trials.	+	-	nl	BMJ 336(7645):645-51 (2008) Strippoli GF
2	2010	Use of statins in patients with chronic hepatitis C.	+	-	nl	South Med J 103(10):1018-22; quiz 1023 (2010)
3	2006	Primary evaluation and management of statin therapy complications.	+	-	nl	South Med J 99(3):250-6 (2006)
4	2008	Interaction between statins and clopidogrel: is there anything clinically relevant?	+	-	nl	QJM 101(12):915-25 (2008)
5	2006	Statins in patients with chronic kidney disease: evidence from systematic reviews and randomized clinical trials.	+	-	nl	PLoS Med 3(5):e123 (2006)
6	2006	Primary prevention of cardiovascular diseases with statin therapy: a meta-analysis of randomized controlled trials.	+	-	nl	Arch Intern Med 166(21):2307-13 (2006)
7	2002	Therapy with hydroxymethylglutaryl coenzyme a reductase inhibitors (statins) and associated risk of incident cardiovascular events in older adults: evidence from the Cardiovascular Health Study.	+	-	nl	Arch Intern Med 162(12):1395-400 (2002) Lemaitre RN
8	1999	Clinical outcomes in statin treatment trials: a meta-analysis.	+	-	nl	Arch Intern Med 159(15):1793-802 (1999)
9	2008	Perioperative statins: more than lipid-lowering?	+	-	nl	Cleve Clin J Med 75(9):654-62 (2008)
10	2005	Safety of statins: effects on muscle and the liver.	+	-	nl	Cleve Clin J Med 72(11):990-3, 996-1001 (2005)
11	2005	Statins: the case for higher, individualized starting doses.	+	-	nl	Cleve Clin J Med 72(9):811-6 (2005) Jones PH
12	2001	Statin myopathies: pathophysiologic and clinical perspectives.	+	-	nl	Clin Invest Med 24(5):258-72 (2001)
13	2004	The cellular biochemistry of cholesterol and statins: insights into the pathophysiology and therapy of Alzheimer's disease.	+	-	nl	CNS Drug Rev 10(2):127-46 (2004)
14	2005	Statins and cognition: what can we learn from existing randomized trials?	+	-	nl	CNS Spectr 10(11):867-74 (2005)
15	2006	American, British and European recommendations for statins in the primary prevention of cardiovascular disease applied to British men studied prospectively.	+	-	nl	Heart 92(9):1213-8 (2006)
16	2009	Reducing morbidity and mortality in high risk patients with statins.	+	-	nl	Vasc Health Risk Manag 5(2):495-507 (2009)
17	2008	Clinical efficacy and safety of statins in managing cardiovascular risk.	+	-	nl	Vasc Health Risk Manag 4(2):341-53 (2008)
18	2005	Ongoing clinical trials of the pleiotropic effects of statins.	+	-	nl	Vasc Health Risk Manag 1(1):29-40 (2005)
19	2006	Statins in the treatment of chronic heart failure: biological and clinical considerations.	+	-	nl	Cardiovasc Res 71(3):443-54 (2006)
20	2005	Cardiac effects of statins--advancements and open questions.	+	-	nl	Cardiovasc Res 66(3):427-9 (2005)
21	2005	Statins--is there no end to their usefulness?	+	-	nl	Cardiovasc Res 65(2):296-8 (2005)
22	2001	Vascular effects of HMG CoA-reductase inhibitors (statins) unrelated to cholesterol lowering: new concepts for cardiovascular disease.	+	-	nl	Cardiovasc Res 49(2):281-7 (2001)
23	2007	A systematic review and economic evaluation of statins for the prevention of coronary events.	+	-	nl	Health Technol Assess 11(14):1-160, iii-iv (2007)
24	2003	The statins as anticancer agents.	+	-	nl	Clin Cancer Res 9(1):10-9 (2003)
25	2006	Why should statins prevent venous thromboembolism? A systematic literature search and a call for action.	+	-	nl	J Thromb Haemost 4(9):1925-7 (2006) Squizzato A
26	2009	Narrative review: statin-related myopathy.	+	-	nl	Ann Intern Med 150(12):858-68 (2009)
27	2001	Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors.	+	-	nl	Arterioscler Thromb Vasc Biol 21(11):1712-9 (2001)
28	2009	Inhibition of RhoA or Rac1? Mechanism of cholesterol-independent beneficial effects of statins.	+	-	nl	Circ J 73(2):231-2 (2009)
29	2007	Peroxisome proliferator-activated receptors mediate pleiotropic actions of statins.	+	-	nl	Circ Res 100(10):1394-5 (2007) Paumelle R
30	2006	Risks associated with statin therapy: a systematic overview of randomized clinical trials.	+	-	nl	Circulation 114(25):2788-97 (2006)
31	2007	HMG-CoA reductase inhibitors and renal function.	+	-	nl	Clin J Am Soc Nephrol 2(6):1100-3 (2007) Campese VM
32	2009	Statin-induced diabetes: will it change clinical practice?	+	-	nl	Diabetes Care 32(10):1941-3 (2009) Belalcazar LM
33	2009	Statin therapy and risk of developing type 2 diabetes: a meta-analysis.	+	-	nl	Diabetes Care 32(10):1924-9 (2009)
34	2006	Statins for improving renal outcomes: a meta-analysis.	+	-	nl	J Am Soc Nephrol 17(7):2006-16 (2006)
35	2006	REVIEW: Efficacy and mechanisms of action of statins in the treatment of diabetic dyslipidemia.	+	-	nl	J Clin Endocrinol Metab 91(2):383-92 (2006)
36	2002	Clinical review 145: Pleiotropic effects of statins: lipid reduction and beyond.	+	-	nl	J Clin Endocrinol Metab 87(4):1451-8 (2002)
37	1992	The discovery and development of HMG-CoA reductase inhibitors.	+	-	nl	J Lipid Res 33(11):1569-82 (1992)
38	2006	Statins and cancer risk: a meta-analysis.	+	-	nl	JAMA 295(1):74-80 (2006)
39	2007	The use of statins in pediatrics: knowledge base, limitations, and future directions.	+	-	nl	Pediatrics 119(2):370-80 (2007)
40	2002	ACC/AHA/NHLBI Clinical Advisory on the Use and Safety of Statins.	+	-	nl	Stroke 33(9):2337-41 (2002)
41	2005	Pleiotropic effects of statins: benefit beyond cholesterol reduction? A meta-regression analysis.	+	-	nl	J Am Coll Cardiol 46(10):1855-62 (2005)
42	2008	The efficacy and safety of intensive statin therapy: a meta-analysis of randomized trials.	+	-	nl	CMAJ 178(5):576-84 (2008)
43	2007	Does pravastatin promote cancer in elderly patients? A meta-analysis.	+	-	nl	CMAJ 176(5):649-54 (2007) Bonovas S
44	2008	Statin adverse effects : a review of the literature and evidence for a mitochondrial mechanism.	+	-	nl	Am J Cardiovasc Drugs 8(6):373-418 (2008)
45	2011	Effect of statins on atrial fibrillation: collaborative meta-analysis of published and unpublished evidence from randomised controlled trials.	+	-	nl	BMJ 342(-):d1250 (2011)
46	2011	Statin myopathy: a common dilemma not reflected in clinical trials.	+	-	nl	Cleve Clin J Med 78(6):393-403 (2011)
47	2009	Statins and noncardiac surgery: current evidence and practical considerations.	+	-	nl	Cleve Clin J Med 76 Suppl 4(-):S79-83 (2009)
48	2007	Effects of statins on renal function.	+	-	nl	Mayo Clin Proc 82(11):1381-90 (2007)
49	2007	Do statins reduce blood pressure?: a meta-analysis of randomized, controlled trials.	+	-	nl	Hypertension 49(4):792-8 (2007)
50	2002	Immunomodulatory effects of statins: mechanisms and potential impact on arteriosclerosis.	+	-	nl	J Am Soc Nephrol 13(6):1673-81 (2002)
51	2005	Are 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors renoprotective?	+	-	nl	J Am Soc Nephrol 16 Suppl 1(-):S11-7 (2005)
52	2002	Statin therapy: beyond cholesterol lowering and antiinflammatory effects.	+	-	nl	Circulation 105(25):2937-8 (2002)
53	2004	Impact of angiotensin-converting enzyme inhibitors and statins on survival in idiopathic pulmonary fibrosis.	+	-	nl	Chest 126(2):438-46 (2004)
54	2009	Statins in COPD: a systematic review.	+	-	nl	Chest 136(3):734-43 (2009)
55	2009	Antimicrobial and immunomodulatory attributes of statins: relevance in solid-organ transplant recipients.	+	-	nl	Clin Infect Dis 48(6):745-55 (2009)
56	2011	Mevalonate pathway is a novel target for hypertension.	+	-	nl	Circ J 75(6):1318-9 (2011) Kishi T
57	2010	Sympathoinhibitory effects of atorvastatin in hypertension.	+	-	nl	Circ J 74(12):2552-3 (2010) Kishi T
58	2010	Pleiotropic effects of statins. - Basic research and clinical perspectives -.	+	-	nl	Circ J 74(5):818-26 (2010)
59	2010	Novel lipid mediators promote resolution of acute inflammation: impact of aspirin and statins.	+	-	nl	Circ Res 107(10):1170-84 (2010)
60	2003	Endothelium-dependent effects of statins.	+	-	nl	Arterioscler Thromb Vasc Biol 23(5):729-36 (2003)
61	2003	Rapid effects of statins: from prophylaxis to therapy for ischemic stroke.	+	-	nl	Arterioscler Thromb Vasc Biol 23(2):156-7 (2003)
62	2007	A systematic review and meta-analysis of statin therapy in children with familial hypercholesterolemia.	+	-	nl	Arterioscler Thromb Vasc Biol 27(8):1803-10 (2007)
63	2007	Do statins have an antiarrhythmic activity?	+	-	nl	Cardiovasc Res 75(1):10-20 (2007)
64	2010	Effect of statin treatment on vasospasm, delayed cerebral ischemia, and functional outcome in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis update.	+	-	nl	Stroke 41(1):e47-52 (2010)
65	2010	'Yes' or 'no' to routine statins after subarachnoid hemorrhage to prevent delayed cerebral ischaemia, vasospasm, and death? A cautionary tale of 2 meta-analyses.	+	-	nl	Stroke 41(1):e1-2 (2010) Sandercock P
66	2008	Statin therapy for stroke prevention.	+	-	nl	Stroke 39(3):1042-8 (2008)
67	2008	Effect of statins on intracerebral hemorrhage outcome and recurrence.	+	-	nl	Stroke 39(7):2151-4 (2008)
68	2004	Statins for primary and secondary prevention of coronary heart disease. A scientific review.	+	-	nl	Rev Port Cardiol 23(1):95-122 (2004)
69	2007	The role of statins in aortic stenosis. Myth or reality?	+	-	nl	Rev Port Cardiol 26(1):51-62 (2007)
70	2010	Effect of statins on HDL-C: a complex process unrelated to changes in LDL-C: analysis of the VOYAGER Database.	+	-	nl	J Lipid Res 51(6):1546-53 (2010)
71	2008	Pharmacogenomics of cardiovascular pharmacology: molecular network analysis in pleiotropic effects of statin -- an experimental elucidation of the pharmacologic action from protein-protein interaction analysis.	+	-	nl	J Pharmacol Sci 107(1):15-9 (2008)
72	2009	ASH evidence-based guidelines: statins in the prevention of venous thromboembolism.	+	-	nl	Hematology Am Soc Hematol Educ Program -(-):273-4 (2009)
73	2006	Lipid-lowering drugs.	+	-	nl	Cell Mol Life Sci 63(10):1165-78 (2006)
74	2002	Isoprenoids as mediators of the biological effects of statins.	+	-	nl	J Clin Invest 110(3):285-8 (2002)
75	2002	Statin drugs and dietary isoprenoids downregulate protein prenylation in signal transduction and are antithrombotic and prothrombolytic agents.	+	-	nl	Biochemistry (Mosc) 67(1):85-91 (2002)
76	2005	HMG CoA reductase inhibitors (statins) to treat Epstein-Barr virus-driven lymphoma.	+	-	nl	Br J Cancer 92(9):1593-8 (2005)
77	2009	Targeting targets for LDL-lowering therapy: lessons from the Collaborative Atorvastatin Diabetes Study (CARDS).	+	-	nl	Clin Chem 55(3):391-3 (2009)
78	2002	Statins: rhabdomyolysis and myopathy.	+	-	nl	CMAJ 166(1):85-6, 90-1 (2002)
79	2011	Novel mechanistic and clinical implications concerning the safety of statin discontinuation.	+	-	nl	Pharmacol Rep 63(4):867-79 (2011)
80	2011	Statin-induced myopathies.	+	-	nl	Pharmacol Rep 63(4):859-66 (2011)
81	2005	Drug-induced myopathies. An overview of the possible mechanisms.	+	-	nl	Pharmacol Rep 57(1):23-34 (2005)
82	2007	Statins: a new insight into their mechanisms of action and consequent pleiotropic effects.	+	-	nl	Pharmacol Rep 59(5):483-99 (2007)
83	2010	Do statins slow the process of calcification of aortic tissue valves?	+	-	nl	Interact Cardiovasc Thorac Surg 11(3):297-301 (2010)
84	2010	Benefits of statin therapy and compliance in high risk cardiovascular patients.	+	-	nl	Vasc Health Risk Manag 6(-):843-53 (2010)
85	2009	The acute (cerebro)vascular effects of statins.	+	-	nl	Anesth Analg 109(2):572-84 (2009)
86	2009	Statins for all: the new premed?	+	-	nl	Br J Anaesth 103(1):99-107 (2009)
87	2008	Statins and sepsis.	+	-	nl	Br J Anaesth 100(3):288-98 (2008)
88	2004	Beneficial effects of statins on the kidney.	+	-	nl	J Clin Pathol 57(7):673-4 (2004)
89	2010	A historical perspective on the discovery of statins.	+	-	nl	Proc Jpn Acad Ser B Phys Biol Sci 86(5):484-93 (2010)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.